LeonaBio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
LeonaBio, Inc. (LONA) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 105.98% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2026-08-14
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2026-03-31 was 106.31%, a 5.83% increase year-over-year.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2025-03-31 was 100.45%, a 4.03% increase year-over-year.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2024-03-31 was 96.56%, a 2.71% decline year-over-year.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2023-03-31 was 99.25%, a 7.12% increase year-over-year.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2025 was 102.99%, a 5.95% increase from fiscal 2024.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2024 was 97.21%, a 1.99% decline from fiscal 2023.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2023 was 99.18%, a 6.70% increase from fiscal 2022.
- LeonaBio, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2022 was 92.95%, a 2.24% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month |
|---|---|---|---|---|
| 2026-06-30 | 105.98% 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | 106.31% 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 102.99% 10-K · filed 2026-03-31 | |||
| 2025-09-30 | 100.54% 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | 100.54% 10-Q · filed 2026-08-14 | |||
| 2025-03-31 | 100.45% 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | 97.21% 10-K · filed 2026-03-31 | |||
| 2024-09-30 | 96.93% 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | 96.93% 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | 96.56% 10-Q · filed 2025-05-09 | |||
| 2023-12-31 | 99.18% 10-K · filed 2025-02-27 | |||
| 2023-09-30 | 99.18% 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | 99.09% 10-Q · filed 2024-08-01 | |||
| 2023-03-31 | 99.25% 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | 92.95% 10-K · filed 2024-02-22 | |||
| 2022-09-30 | 92.87% 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | 92.78% 10-Q · filed 2023-08-10 | |||
| 2022-03-31 | 92.65% 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | 90.91% 10-K · filed 2023-03-23 | |||
| 2021-09-30 | 89.34% 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | 89.34% 10-Q · filed 2022-08-15 | |||
| 2021-03-31 | 89.13% 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | 87.41% 10-K · filed 2022-03-28 | |||
| 2020-09-30 | 80.11% 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | 78.15% 10-Q · filed 2021-08-16 | |||
| 2020-03-31 | 78.17% 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | 75.00% 10-K · filed 2021-03-25 | |||
| 2019-09-30 | 74.59% 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |